About Novosanis
Novosanis is a Healthcare company based in Wijnegem (Belgium) founded in 2013, and was acquired by OraSure in January 2019. Sampling and Intradermal Injection device. Novosanis offers products and services including Colli-Pee. Its focus areas include Life Sciences, Drug Delivery and Patches. Its legal entity is Novosanis NV.
Company details
Novosanis was founded in 2013 and is based in Wijnegem, Belgium. Operations focus on the medical technology sector, where products are developed and commercialized to enhance diagnostic accuracy and drug administration. Key offerings include the VAX-ID device for precise intradermal delivery of vaccines and therapeutics, and the Colli-Pee device for collecting first-void urine to detect infectious diseases and early-stage cancers.
- InvestorsOraSure Technologies
& 5 more
- Acquired byOraSure
(Jan 2019)
Products & Services of Novosanis
Novosanis offers a comprehensive portfolio of products and services, including Colli-Pee.
Device for sample collection in tests for infectious diseases.
Apps and channels of Novosanis
its YouTube channel Novosanis has 62 subscribers and 19 videos.
Videos from Novosanis
The most watched videos on Novosanis's YouTube channel, Novosanis (62 subscribers). Click a video to play it here.
More on Novosanis.
Funding Insights of Novosanis
- Total Rounds 6
- First Round $334,103
(Aug 2014)
- Investors Count 5
All 6 funding rounds of Novosanis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2017 | Seed | – | – | ||
| Oct 2015 | $55,006 | Grant | – | – | |
| Sep 2015 | Seed | – | – | ||
| Sep 2015 | Grant | – | – | ||
| Sep 2015 | $56,465 | Grant | – | – | |
| Aug 2014 | $334,103 | Grant | – | – |
6 investors in total: 6 institutional.
Investors in Novosanis
Novosanis has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include OraSure Technologies, European Commission and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| tastewesterlund.com | ||||
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Institution of the European Union responsible for upholding the EU treaties | 1958 | ec.europa.eu | Brussels, Belgium | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
A platform for online casino gaming in Belgium is provided. | iwt.be | Belgium | ||
Point-of-care diagnostic devices for oral fluid specimens are provided. | 1987 | orasure.com | Bethlehem, United States |
Investor details for Novosanis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Novosanis
4 dated milestones of Novosanis across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Novosanis is founded.
- Funding First funding round of $334K.
- Funding Latest funding round, Seed,.
- Exit Acquired by OraSure.
Web traffic of Novosanis
Websites that share an audience with Novosanis (novosanis.com).
Websites whose visitors overlap most with Novosanis. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
brooksidepress.org | brooksidepress.org | 100% | #804,753 | – | |
| bd.com | 100% | 1.2M | #57,463 | View details | |
pharmaceutical-drug-manufacturers.com | pharmaceutical-drug-manufacturers.com | 60% | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Novosanis
Complete news archive for Novosanis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novosanis
Novosanis was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Novosanis is headquartered in Wijnegem, Belgium. It is registered at Wijnegem, Antwerp, Belgium.
Novosanis was founded in 2013 and is based in Wijnegem, Belgium. Operations focus on the medical technology sector, where products are developed and commercialized to enhance diagnostic accuracy and drug administration. Key offerings include the VAX-ID device for precise intradermal delivery of vaccines and therapeutics, and the Colli-Pee device for collecting first-void urine to detect infectious diseases and early-stage cancers.
Novosanis offers Colli-Pee.
Novosanis has 6 investors. Key investors include OraSure Technologies, European Commission, European Union, Taste Westerlund, and EIC Fund.
Novosanis operates through Novosanis Nv.
Yes. Novosanis was acquired by OraSure in January 2019.